Hinxton, United Kingdom

Mike Stratton

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: The Wellcome Trust Limited, Genome Research Limited. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mike Stratton. Retrieved from https://idiyas.com/inventor/mike-stratton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mike Stratton

Introduction

Mike Stratton, an accomplished inventor based in Hinxton, GB, has made significant strides in the field of genetic research. With three patents to his name, Stratton is recognized for his innovative approaches to detecting mutations that play a critical role in cancer diagnosis and treatment.

Latest Patents

Stratton's latest patents reflect his expertise in genomics. One of these patents is a method of detecting a mutational signature in a DNA sample. This invention provides a detailed process for identifying mutations arising from rearrangements in the DNA and analyzing their contributions. The method involves computing cosine similarity between rearrangement mutations and mutational signatures, classifying these findings based on their nature, such as clustered or non-clustered, tandem duplications, deletions, inversions, or translocations.

Another notable patent that Stratton holds addresses the detection of the oncogenic T1796A B-Raf mutation. This invention focuses on mutations in B-Raf gene products, which are found in human tumors of natural origin. These mutations are crucial as they are associated with cancerous phenotypes, providing a foundation for the diagnosis of cancer and potential development of anti-cancer therapeutics.

Career Highlights

Throughout his career, Stratton has been affiliated with prestigious organizations, including The Wellcome Trust Limited and Genome Research Limited. His work in these institutions has greatly influenced the landscape of cancer research and treatment options available today.

Collaborations

Stratton has collaborated with esteemed colleagues such as Andy Futreal and Richard Wooster, further enhancing his contributions to the world of genetic research. These collaborative efforts have paved the way for groundbreaking advancements in the understanding and diagnosis of genetic mutations.

Conclusion

Mike Stratton's innovations in the field of genetics not only demonstrate his commitment to scientific progress but also highlight the importance of research in understanding complex diseases like cancer. His patents are a testament to the ongoing efforts to improve diagnostics and therapeutic strategies, ultimately benefiting countless individuals facing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…